Clinical Trials Directory

Trials / Completed

CompletedNCT01272284

The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Coloplast A/S · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

An international, multi-center, single arm, prospective clinical study designed to assess the safety and efficacy of the Coloplast Altis single incision sling system for females with stress urinary incontinence (SUI).

Detailed description

An international, multi-center, single arm, prospective clinical study designed to assess the safety and efficacy of the Coloplast Altis single incision sling system for females with stress urinary incontinence (SUI). Primary Objective: Improvement in continence measured by 24 hour pad weight test with at least a 50% reduction in weight from baseline at 6 months. Secondary Objectives: Cough stress test results at 6 months; Subject QoL as measured by validated questionnaires: PGI-I, improvements in UDI-6 and IIQ-7 scores from baseline at 6 months, 3 day voiding diary improvement from baseline at 6 months; Device and procedure related adverse events. Brief Entrance Criteria: Adult female with confirmed SUI through cough stress test or urodynamics; Failed two non-invasive incontinence therapies; No prior surgical SUI treatment; No prolapse POP-Q Stage 2 or higher; No concurrent pelvic floor procedure; No urge predominant incontinence; No incontinence due to neurological disorder/disease; No PVR \> 100cc; and, No contraindication to the surgical procedure. Study visits will take place at baseline, implant/hospitalization, 3 months, 6 months, 1 year, and 2 years post operatively. This study will enroll up to 113 subjects at up to 17 investigative sites in the US and Internationally.

Conditions

Interventions

TypeNameDescription
DEVICEAltis® Single Incision Sling System (SIS)The Altis® SIS is a permanently implantable synthetic sling for females placed at the mid-urethra to provide a scaffold for tissue in-growth and support for stress urinary incontinence.

Timeline

Start date
2010-12-01
Primary completion
2012-07-01
Completion
2014-01-01
First posted
2011-01-07
Last updated
2021-02-11
Results posted
2013-11-28

Locations

17 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01272284. Inclusion in this directory is not an endorsement.